Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2005
11/09/2005EP1592444A1 Canine vaccines against bordetella bronchiseptica
11/09/2005EP1592443A1 Improved anthrax vaccines and delivery methods
11/09/2005EP1592442A2 Modified free-living microbes, vaccine compositions and methods of use thereof
11/09/2005EP1592441A2 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
11/09/2005EP1592440A2 Immunoglobulin formulation and method of preparation thereof
11/09/2005EP1592387A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592386A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592385A2 Lactate dehydrogenase as a novel target and reagent for diabetes therapy
11/09/2005EP1592383A2 Methods for reducing mortality associated with acute myocardial infarction
11/09/2005EP1425038B1 Attenuated bacteria useful in vaccines
11/09/2005EP1425037B1 Bacterial vaccine
11/09/2005EP1355930B1 A method for identification, isolation and production of antigens to a specific pathogen
11/09/2005EP1287142B1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
11/09/2005EP1261693B1 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1141245B1 Somatic cells with ablated prp gene and methods of use
11/09/2005EP1111048B1 Neutral amino acid transporter and gene thereof
11/09/2005EP1011722B1 Substrates materials with bound cytokine-stimulating polysaccharides or bacterial nucleic acids
11/09/2005EP0977874B1 Attenuated salmonella strain used as a vehicle for oral immunization
11/09/2005EP0960192B1 Synthetic polynucleotides
11/09/2005EP0950068B1 Collagen binding protein compositions and methods of use
11/09/2005EP0946710B1 Methods of preserving prokaryotic cells and compositions obtained thereby
11/09/2005EP0904380B1 Synthetic hiv genes
11/09/2005EP0842278B1 Dnase-active protein
11/09/2005EP0812359B1 Group o hiv-1, fragments of such viruses, and uses thereof
11/09/2005EP0792162B1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
11/09/2005EP0779924B1 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus
11/09/2005EP0760857B1 Receptor for oncostatin m
11/09/2005EP0751992B1 Vascular endothelial growth factor 2
11/09/2005EP0750457B1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/09/2005CN1695059A Method of diagnosing colon and gastric cancers
11/09/2005CN1694901A Kdr peptides and vaccines comprising the same
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694894A Anti-IL-6 antibodies, compositions, methods and uses
11/09/2005CN1694725A Early detection of mycobacterial disease using peptides
11/09/2005CN1694724A Immunization against autologous ghrelin
11/09/2005CN1694723A Vaccine
11/09/2005CN1694722A A process for the preparation of a non-toxic anthrax vaccine
11/09/2005CN1694715A Cancer therapy using beta glucan particles and antibodies
11/09/2005CN1694490A Method, equipment and computer program of changed digital color image
11/09/2005CN1226414C CAMP factor of streptococcus uberis
11/09/2005CN1226413C Trichina TS88 gene, their protein products and uses
11/09/2005CN1226410C CR1 gene related to cell reconstitution, conduction and death
11/09/2005CN1226406C Attenuated live neospora vaccine
11/09/2005CN1226046C Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor and pharmaceutical compositions containing same
11/08/2005US6962988 Comprises deiminase polypeptide for sterilization of female animals and/or the generation of antibodies useful for temporary, reversible contraception
11/08/2005US6962987 Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins
11/08/2005US6962982 Diagnosis of human immunodeficiency virus
11/08/2005US6962980 Stimulant immunology response; polynucleotides
11/08/2005US6962978 Multiple sclerosis; immobilization; water solubility
11/08/2005US6962969 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/08/2005US6962813 P. aeruginosa mucoid exopolysaccharide specific binding peptides
11/08/2005US6962710 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/08/2005US6962709 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
11/08/2005US6962708 Chimeric flavivirus vaccines
11/08/2005US6962707 Therapeutic agent comprising immunogenic, natural A beta peptide with adjuvant alum to enhance the immune response; conjugated A beta fragment with carrier T cell epitope; Alzheimer's disease
11/08/2005US6962706 for use in raising immune response against Porphyromonas gingivalis, comprising suitable adjuvant, carrier or excipient and peptide of not more than 50 amino acids including P. gingivalis epitope comprising sequence RYDDFTFEAGKKYTFTMRRAGMGDGTD
11/08/2005US6962704 Administering protein Q or a variant thereof containing modifications or substitutions of preserved amino acid residues, protein Q or variant thereof being optionally combined with complete or fragmented protein LiHsp70 and
11/08/2005US6962703 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
11/08/2005US6962702 Diagnosis of tissue damage, cancer
11/08/2005US6962701 Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
11/08/2005US6962694 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
11/08/2005CA2293401C A method for depleting viral and molecular pathogens in a biological material
11/08/2005CA2251690C New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
11/08/2005CA2153806C Detection and treatment of mutations in a cd40 ligand gene
11/06/2005CA2504403A1 Prognostic for hematological malignancy
11/03/2005WO2005103303A2 Apparatus and method for transdermal delivery of multiple vaccines
11/03/2005WO2005103302A2 Mutant viral nucleic acids and vaccine containing same
11/03/2005WO2005103291A1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2005WO2005103288A1 Screening method
11/03/2005WO2005103259A1 Sars-cov nucleocapsid protein epitopes and uses thereof
11/03/2005WO2005103250A1 THERAPEUTIC MEDICINE CONTAINING MONOCLONAL ANTIBODY AGAINST FOLATE RECEPTOR BETA (FR-β)
11/03/2005WO2005103243A2 Carboxypeptidases b from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets
11/03/2005WO2005103240A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 1 (csnk1d iso 1)
11/03/2005WO2005103236A1 A method for proliferating hepatitis c virus by using normal cells
11/03/2005WO2005103235A1 Method of producing virus
11/03/2005WO2005103088A1 A single-domain antibody strengthening fusion protein vh-ldp-ae
11/03/2005WO2005103082A2 Group 1 mite polypeptide variants
11/03/2005WO2005103081A2 Human monoclonal antibodies against cd20
11/03/2005WO2005103073A2 Td antigens
11/03/2005WO2005103071A1 Peptide inhibitors of metalloproteinase activity
11/03/2005WO2005102938A2 Antibodies specific for bcr-abl fusion protein and uses thereof
11/03/2005WO2005102394A1 Uric acid as adjuvant
11/03/2005WO2005102387A2 Therapeutic use of anti-cs1 antibodies
11/03/2005WO2005102386A1 Treatment of fungal infections
11/03/2005WO2005102385A1 Adjuvant composition and methods for its use
11/03/2005WO2005102384A2 Immunising against meningococcal serogroup y using proteins
11/03/2005WO2005102383A1 Antigen specific t cell therapy
11/03/2005WO2005102369A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005WO2005102278A1 Method for preparation of poly-iclc and uses thereof
11/03/2005WO2005101966A2 Lipid-extracted therapeutic vaccine and method of use
11/03/2005WO2005089762A3 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition
11/03/2005WO2005071067A3 Non-animal origin stabilizers and processes for producing the same
11/03/2005WO2005070454A3 A novel process of hepatitis a vaccine preparation
11/03/2005WO2005060713A3 Method of inhibiting candida-related infections using donor selected or donor stimulated immunoglobulin compositions
11/03/2005WO2005059123A3 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders
11/03/2005WO2005058961A3 Antibodies specific for human galanin, and uses thereof
11/03/2005WO2005056598A3 Laminin-5 modulators and uses thereof
11/03/2005WO2005055957A3 Influenza immunogen and vaccine
1 ... 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 ... 1823